Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study

  Delphine Rea ¹ AuthorId : 797328
Author

  Franck Nicolini ² AuthorId : 493593
Author

  Michel Tulliez AuthorId : 802358
Author

  François Guilhot ³ AuthorId : 464541
Author

  Joëlle Guilhot ⁴ AuthorId : 449357
Author

  Agnès Guerci-Bresler ⁵ AuthorId : 635666

Author

  Martine Gardembas ⁶ AuthorId : 464499
Author

  Valérie Coiteux ⁷ AuthorId : 464490
Author

  Gaëlle Guillerm ⁸ AuthorId : 974502
Author

  Laurence Legros ⁹ AuthorId : 354461
Author

  Gabriel Etienne ¹⁰ AuthorId : 104600
Author

  Jean-Michel Pignon AuthorId : 757267
Author

  Bruno Villemagne ¹¹ AuthorId : 11113525
Author

  Martine Escoffre-Barbe ¹² AuthorId : 725609
Author

  Jean-Christophe Ianotto ^{13, 14, 15} AuthorId : 496223
Author

  Aude Charbonnier AuthorId : 489776
Author

  Hyacinthe Johnson-Ansah AuthorId : 1006294
Author

  Marie-Pierre Noel AuthorId : 11420575
Author

  Philippe Rousselot ¹⁶ AuthorId : 377779
Author

  François Mahon AuthorId : 11420576
Author